The Holding Foreign Companies Accountable Act (“HFCAA”)1, in December 2020 passed by the Congress and signed into law by then-president of the United States, Donald J. Trump, is one of the most influential measures in the...more
11/10/2022
/ Capital Markets ,
China ,
Foreign Corporations ,
Foreign Issuers ,
Holding Foreign Companies Accountable Act (HFCAA) ,
Hong Kong ,
Investor Protection ,
Nasdaq ,
NYSE ,
PCAOB ,
Publicly-Traded Companies ,
Risk Management ,
Securities and Exchange Commission (SEC)
Historically, the US, and, in particular, the NASDAQ market, has been the predominant place for IPOs of life sciences and healthcare companies. However, 2018 may be the year in which things start to change....more
3/13/2018
/ Capital Markets ,
CFDA ,
China ,
Health Care Providers ,
Hong Kong ,
Hong Kong Stock Exchange ,
Institutional Investors ,
Life Sciences ,
Listing Rules ,
Listing Standards ,
New Rules ,
NYSE ,
Regulatory Oversight